Scoring system
for papillary thyroid carcinoma - a histopathological study
Prabhu S.C.1,
Umashankar T.2
1Dr.
Swathi C. Prabhu, Assistant Professor, Department of Pathology, Melaka Manipal Medical College,
Manipal, Karnataka, 2Dr. Umashankar
T., Professor, Department of Pathology, Father Muller Medical College,
Mangalore, Karnataka, India.
Corresponding Author: Dr. Swathi C. Prabhu, Manjunath
Krupa, Temple Road, Saralebettu, Manipal, Udupi District Karnataka, India. E-mail:
prabhuswathi15@gmail.com
Abstract
Background:
Cancer of the thyroid gland is the most common endocrine malignant neoplasm,
and papillary thyroid carcinoma (PTC) accounts for majority of the cases. PTC cases
are identified by its distinct histopathological features. Due to lack of
definable criteria and overlapping features seen in other diseases of thyroid giving
rise to false positive cases and errors in diagnosis may reflect drastically on
the prognosis and treatment outcome. Objective:
To analyse the frequency of PTC microscopic criteria in a series of benign
lesions of thyroid and PTC cases and to build an optimal cut off score which
could help us differentiate between these cases. Materials and Methods: The study included 86 thyroid lesions, 43
benign and 43 PTC cases. Histopathological parameters analysed included colloid, papillae, nuclear
crowding, nuclear grooving, nuclear enlargement, oval nucleus, nuclear
clearing. Results:
The above mentioned parameters could differentiate between benign and PTC cases.
Based on sensitivity and specificity, the cut off derived for every parameter
is as follows: colloid <50%, papillae >1%, nuclear crowding >25%,
nuclear grooving >5%, nuclear enlargement >50%, ovoid nucleus >25%,
nuclear clearing>50%. The scoring system was built based on these
parameters. The score proposed helped us to classify benign and PTC cases. PTC
cases scored a total score of >7 indicating that seven can be considered as cut
off value to differentiate between benign and PTC cases. Conclusion: Definite distinction between benign and PTC cases was possible
when all the parameters were clubbed together with an important role in cases
with diagnostic dilemma.
Key words:
Microscopic criteria, Adenomatous nodule, Follicular adenoma, papillary thyroid
carcinoma, Thyroid.
Author Corrected: 26th December 2018 Accepted for Publication: 31st December 2018
Introduction
papillary
thyroid carcinoma (PTC) is the most common malignant neoplasm of thyroid
accounts for 80-85% of the cases. The most
common etiologic factor is radiation, but genetic susceptibility and other
factors also contribute to the development of PTC. Generally, PTC has a favourable
prognosis, with long-term survival rates greater than 90% particularly in patients
younger than 45 years [1,2]. Right diagnosis and appropriate treatment helps in
achieving desired results. PTCs are identified by its distinct
histopathological features such as papillary architecture, nuclear clearing,
ground glass or Orphan Annie-eyed appearance, oval shaped nuclear enlargement,
powdery chromatin, intranuclear cytoplasmic inclusions, nuclear grooving, and
nuclear overlapping [3]. In India, as per Mumbai Cancer Registry, age adjusted
incidence rates are about 1 for males and 1.8 for females per 100,000 populations.
Frequency of thyroid cancer among all cancer cases was 0.1%-0.2% [4]. There has
been substantial increase in incidence rates due to awareness and increase in
early detection by MRI and CT of non-palpable nodules. Papillary micro-carcinomas(less
than 1cm size) have an excellent prognosis [3,5].
Most
commonly PTC presents as a solitary nodule or as cervical lymphadenopathy, cold
nodule on radioactive iodine scan. Fine needle
aspiration of thyroid lesion or lymph node helps in the initial diagnosis
preoperatively. Grossly they present as grey white masses with infiltrative borders.
Some may present with cystic change and some with calcified areas. The lymphatics,
being the most common route of metastasis and hence these tumours might present
as cervical lymphadenopathy [1, 6].
Histopathology remains as a gold standard for diagnosis of
PTC. It is characterised by its distinct nuclear features which include,
nuclear enlargement, nuclear overlapping, oval nucleus, nuclear grooves, and
nuclear inclusions. Papillae, psammoma bodies, thick colloid, multinucleated
cells are also noted [7].
Papillae are also noted in nodular goitre, follicular
adenoma, diffuse hyperplasia and are usually not seen in follicular variant of
PTC. Nuclear features though focally are noted in a variety of lesions
including adenomatous nodules, Hashimoto’s thyroiditis. These cases may also
show areas of nuclear clearing, nuclear crowding, grooving. These overlapping
features pose difficulties in diagnosis and are the reasons for false positive
cases which significantly influence treatment and prognosis [3].
The objectives of this study
· To
analyse, the percentage of tumour cells with each microscopic criterion of PTC
proposed in individual tumour, and the frequency of PTC microscopic criteria in
a series of 86 cases. To determine the optimal cut off for every parameter
based on sensitivity and specificity.
· To
propose an optimal cut off score and to categorise the thyroid tumours in to
benign and PTC based on this score.
Materials and Methods
Place of study: The
present study was conducted in Father Muller medical college, tertiary care centre
from May 2013 to October 2016.
Type of study:
Comparative study between benign and PTC cases.
Sampling method:
Retrospective study 43 benign and 43 PTC cases were studied.
Inclusion criteria:
Malignant cases included classical and follicular variant of PTC (FVPTC) (>1cm).Benign
cases included were follicular adenoma, Hurthle cell adenoma and adenomatous
nodule.
Exclusion criteria: Rest
of the variants of PTCs, microcarcinomas (<1 cm) and other malignant lesions
of thyroid were excluded from our study. Inflammatory, autoimmune,
granulomatous conditions were also excluded. These cases were retrieved from
archives.
Statistical method:
The parameters were compared between benign and PTC cases. Comparisons of
frequencies among the two groups were performed using the Chi-square test or
Fisher exact test when necessary. Secondly, sensitivity, specificity was
determined at each cut off level that was designed. The cut offs and the
corresponding scores derived was then applied to benign thyroid lesions and PTC
cases
Method and scoring
system: Morphometric analysis was performed on paraffin
embedded Hematoxylin and Eosin (H & E) sections and the following
parameters were formulated and evaluated and scored accordingly as shown below.
A semi quantitative microscopic analysis in four categories (≤25%; >25% and
≤50%; >50% of tumour) was assessed for the following parameters: Colloid,
nuclear crowding, nuclear enlargement, oval nucleus. Papillae were scored as
<1% and >1% and nuclear grooving as <5% and >5%. 10 high power
fields were evaluated in 10 consecutive fields with a gap maintained between
the two fields to avoid overlapping. Six to 10 nuclei when seen closely packed
together, was considered as nuclear crowding. Nuclear enlargement was
considered when the size was four to six times of the size of small lymphocyte.
Nuclear clearing was estimated by counting number of cells showing clearing per
high power field and multiplying by area in percentage (Table 1). The
involvement was considered focally when the area involved was <25%.
Table-1: Grading of various
parameters
Parameters |
Grade |
Score |
Colloid |
<25% 25-50% >50 |
3 2 1 |
Papillae |
<1% >1% |
1 2 |
Nuclear crowding Area in % |
<25% 25-50% >50% |
1 2 3 |
Nuclear grooving Area in % |
<5% >5% |
1 2 |
Nuclear enlargement Area in % |
<25% 25-50% >50% |
1 2 3 |
Oval nucleus Area in % |
<25%
-1 25-50
%-2 >50
-3 |
1 2 3 |
Nuclear clearing Cells x area in % |
<10%
-1 <25%-1 10-50%
-2 x 25-50%-2 >50
-3 >50%-3 |
1,2,3,4,6,9 |
After
measurement, the data were transferred to MS-Excel sheet for further analysis.
These parameters were compared between benign and PTC cases. Comparisons of frequencies
among the two groups were performed using the Chi-square test or Fisher exact
test when necessary. Secondly, sensitivity, specificity was determined at each
cut off level that was designed. The cut offs and the corresponding scores
derived was then applied to benign thyroid lesions and PTC cases. The score
proposed is given below (Table 2).
Table-2: Cut offs and corresponding
scores on each microscopic criterion
Parameter |
Absent |
Present |
Colloid (<50%) |
0 |
2 |
Papillae (>1%) |
0 |
2 |
Nuclear crowding (>25%) |
0 |
2 |
Nuclear grooving (>5%) |
0 |
2 |
Nuclear enlargement (>50%) |
0 |
3 |
Oval nucleus (>25%) |
0 |
2 |
Nuclear clearing (>50%) |
0 |
4 |
For
all statistical tests, a p value of
less than 0.05 was considered to indicate a significant difference.
Results
Out
of 86 cases, 18(20.8%) were FVPTC and 25(28.7%) were classic variants. Benign
cases studied were 32(37.9%) cases of adenomatous nodule, 5(5.7%) cases of
follicular adenoma and 6(6.9%) cases of Hurthle cell adenoma.
The
presence, the frequency of each PTC microscopic criterion, was evaluated in
PTC, according to the percentage of tumour with the microscopic criteria (Table
3). A quantitative assessment was done
on benign and PTC cases.
Table-3: Frequency of PTC
microscopic criteria in PTC and benign thyroid lesions
Parameters |
Status |
|
|
PTC |
Benign |
Colloid
3 (<25%) 2 (25-50%) 1 (>50%) |
28(65.1%) 15(34.9%) 0
(0%) |
13(30.2%) 16(37.2%) 14(32.6%) |
Papillae
1 (<1%) 2(>1%) |
24(55.8%) 19(44.2%) |
42(97.7%) 1(2.3%) |
Nuclear
crowding 1 (<25%) 2 (25-50%) 3 (>50%)
|
24(55.8%) 17(39.5%) 2(4.7%) |
40(93%) 3(7%) 0(0%) |
Nuclear
grooving 1- <5% 2->5% |
25(58.1%) 18(41.9%) |
41(95.3%) 2(4.7%) |
Nuclear
enlargement1 (<25%) 2
(25-50%) 3
(>50%)
|
0 0 43(100%) |
26(60.5%) 17(39.5%) 0 |
Oval
nucleus 1 (<25%) 2 (25-50%) 3 (>50%)
|
0(0%) 3(7%) 40(93.0%) |
43(100%) 0(0%) 0(0%) |
Nuclear
clearing (Cells x area in %)=score <10%
-1 <25%-1 1 10-50%
-2 x 25-50%-2 2 >50
-3 >50%-3 3
4
6 9 |
0(0%) 1(2.3%) 15(34.9%) 0(0%) 14(32.6%) 13(30.2%) |
34(79.1%) 6(14%) 2(4.7%) 1(2.3%) 0(0%) 0(0%) |
Seventy
percentage of the benign cases showed colloid status >25% of the area in
contrast to malignant cases which constituted 34.9% cases. Papillae, one of the
most important parameter in classical variant of PTC (55.8%) were seen only in
one (2.3%) of the case in the benign category. Enlarged nuclei constituting
>50% area was seen in almost all PTC cases in contrast to benign cases were
nuclear enlargement was observed focally (<25% area) in 60.5% cases.
Majority of the benign cases(93%) showed focal area of nuclear crowding compared
to malignant cases which were distributed between focal(55.8%) and diffuse (44.2%).
About 93% of the malignant cases showed diffuse oval enlargement of the nucleus
(>50% of the area) compared to benign cases which showed focal enlargement.
Secondly,
based on the p value, the threshold value
was determined for the criteria to allow us a clear distinction between benign
and PTC cases. The threshold value derived was 50% for colloid status, nuclear
crowding, nuclear enlargement, nuclear clearing, 25% for oval nucleus, 5% for
nuclear grooving, and 1% for papillae. These criteria defined were significantly
more frequently observed in PTC than benign cases (p<0.05). Sensitivity and specificity, p value, was determined at the level of cut off and the results are
as follows. P value was considered
significant if <0.05 and highly significant when <0.001.
Table-4: Sensitivity, specificity and
p value at the level of optimal cut
off
Parameter |
Sensitivity |
Specificity |
Diagnostic
accuracy |
Kappa
statistics |
p value |
Nuclear
enlargement (cut off 3)50% |
100.00% |
100.00% |
100.00% |
1.0000 |
<0.001 |
Oval
nucleus (cut off 2)25% |
100.00% |
100.00% |
100.00% |
1.0000 |
<0.001 |
Nuclear
clearing (cut off 4)50% |
62.80% |
97.70% |
80.23% |
0.6050 |
<0.001 |
Papillae
(cut off 2)1% |
46.50% |
97.70% |
72.09% |
0.4420 |
<0.001 |
Colloid
(cut off 2) 50% |
100.00% |
32.60% |
66.28% |
0.3260 |
<0.001 |
Nuclear
grooving (cut off 2)5% |
41.90% |
95.30% |
68.60% |
0.3720 |
<0.001 |
Nuclear
crowding (cut off >50%) |
44.20% |
93.00% |
68.60% |
0.3720 |
<0.001 |
From
the above table it’s clear that nuclear enlargement when diffuse (>50%),
oval nucleus (>25%), nuclear clearing (>50%) are the best parameters
followed by papillae, nuclear crowding, nuclear grooving, colloid status (p<0.001)
are significant is differentiating benign from PTC cases with colloid status (>50%)
indicating towards benign nature of the lesion.
The
scoring derived from our study was applied on 43 benign and 43 PTC cases. Maximum
score was 15 and minimum zero. The below table describes the scoring of various
benign thyroid lesions and PTC cases.
Table-5: Score applied on benign
and PTC cases
Benign thyroid
lesions |
Score |
Adenomatous
nodule |
0-6 |
Follicular
adenoma |
0-4 |
Hurthle
cell adenoma |
0-4 |
Malignant lesions |
Score |
PTC |
9-15 |
FVPTC |
7-13 |
All
benign cases scored less than six compared to malignant cases which scored more
than seven. The classical variant of PTC showed higher score in contrast to FVPTC
which scored low. However, it was >6 compared to benign cases.
Discussion
The main objective behind this
study would be the overlapping features of benign and malignant lesions of
thyroid posing difficulties in the diagnosis and ultimately affecting the
treatment outcome.Unlike follicular carcinomas which require demonstration of
vascular and capsular invasion, PTC diagnosis is based on nuclear features
irrespective of invasion or metastasis although no single morphology will differentiate
PTC from benign lesions [8].
The current study reviewed the
presence, the percentage of tumor presenting with microscopic criteria of PTC
and devised a score based on statistical analysis for the microscopic analysis
of benign and PTC cases. This score included seven criteria with specific
weight: colloid <50% (0 when absent or 2 when present) + papillae >1% (0 when
absent and 2 when present + nuclear crowding > 25% (0 when absent or 2 when
present) + nuclear grooving >5% (0 when absent or 2 when present) + nuclear
enalrgement >50% (0 when absent or 3 when present) + oval nucleus> 25% (0
when absent and 2 when present) + nuclear clearing >50% (0 when absent and 4
when present). The “gold standard” for the diagnosis of PTC still relies on
microscopic features [9].
PTC, classical variant, as we know
shows nuclear clearing, overcrowding, overlapping, abortive papillae. Clearing
is said when nucleus shows peripheral condensation of chromatin giving it
vesicular appearance and nuclear grooving when nucleus folds into itself [9]. About
70% of PTC cases in our study showed clearing followed by 41% of cases showing
grooving. Nuclear grooving which is well appreciated on cytology specimens are
also not specific to PTC cases and can be seen in adenomatous hyperplasia, Hashimoto’s
disease, diffuse hyperplasia etc [10]. This was reflected in our study were
grooving was found to be a specific finding provided they are distributed
diffusely. Ground glass appearance was not specific finding as it is seen in
other benign lesions of thyroid such as nodular hyperplasia, Hashimotos
thyroiditis etc [10, 11]. Nuclear pseudoinclusions which is specific to PTC
cases is excluded in this study due to its close association with malignancy.
Enlargement of the nucleus, ovoid nucleus are other features specific to PTC [10].
This enlargement results in over crowding. In our study, PTC cases showed
nuclear enlargement (>50% area) with 93% showing ovoid nucleus. The Literature
mentions about 90% of the PTC cases showing papillae, sticky colloid in 20%
cases, psammoma bodies in 20-40% cases and nuclear grooving in 88% of the cases
[11,12].
Many thyroid lesions can present with a papillary like features mimicking PTC
and pose a diagnostic problem. Benign lesions of thyroid like hylainizing
trabecular neoplasms, benign papillary hyperplasia, lymphocytic thyroiditis and
also FNA can have papillary like features. Hence, we have to be careful in
identifying the complex branching papillary architecture of PTC from benign
lesions. Apart from classical variant, follicular variant of PTC never shows
papillary architecture. Therefore, the diagnosis was purely based all the
features in unison [3]. In our study, 44.2% cases showed well-formed papillary
structures.
There are several variants of PTC
i.e follicular variant, tall cell variant, warthin like variant, oncocytic,
columnar cell variant, diffuse sclerosing, clear cell etc [13]. Papillae are
uncommonly seen in follicular variant and also the nuclear features are not
pronounced in these cases. Histopathology plays an important role in diagnosing
these cases. Very few studies have been done pertaining to methodical quantification
of the individual feature of PTC cases in the past [14]. Hence in the present
study, special emphasis has been placed to quantify and grade various features
of PTC.
This study emphasises on
morphometry as an objective tool to supplement subjective histopathology
evaluation in differentiating benign from PTC cases. It’s a quantitative analysis
of various parameters i.e colloid, papillae, nuclear enlargement, nuclear grooving,
oval nucleus and nuclear clearing. Over all assessment of these parameters
helps to differentiate between benign and PTC,thus help in the definitive
diagnosis of borderline cases.
In our study, all the parameters
that were considered were highly significant in differentiating benign from PTC
cases (p value <0.0001). Based on
the scoring system proposed score >7 indicates malignancy with FVPTC on the
lower side and classical variant of PTC on the upper side and benign cases less
than 7.
Usually,
PTC cases are easily diagnosed based on nuclear features. However in cases of
follicular variant of PTC were the classic features are subtle and also in
cases of benign cases such as papillary hyperplasia of thyroid and adenomatous
were nuclear features are pronounced, diagnosis becomes subjective and might
result in diagnostic errors. Encapsulated variant of PTC has now renamed as non-invasive
follicular thyroid neoplasm with papillary-like nuclear features” (NIFTP) due
to its highly indolent behaviour [8,15]. In equivocal cases, terminology “well
differentiated thyroid tumour of uncertain malignant potential” was proposed by
Chernobyl pathologists for uncertain nuclear features [16].
In
our study, we first analysed the percentage of various parameters proposed in
benign and PTC cases followed by sensitivity and specificity with p values to each cut off that was
designed. In our study, the parameters were highly variable from cases to case
and all the variables upon integration helped us to give an appropriate
diagnosis. No PTC cases showed colloid status >50% indicating that all the
cases was within 50% status. Nuclear enlargement, oval nucleus, nuclear
clearing when combined together constituted 100% sensitivity and specificity
when the distribution was diffuse (>50%). Our results are comparable with
those of Adeniran et al who also found that nuclear enlargement was present in
a high proportion of tumours cells, optically clear nuclei in a slightly
smaller proportion and nuclear grooves to a variable degree from case to case [17].
For these authors, the presence of nuclear pseudo inclusions was the less
frequent finding among all tumours (54%). Similar results were also seen in a
study conducted by Verhulst et al who stressed the importance of ovoid nucleus,
enlarged nuclei, dark staining colloid, lack of polarisation, nuclear grooves
in determining malignant status of the lesions [9].
After determining the threshold values, it was
observed that all the features were present in malignant cases, with nuclear
features showing the upper hand. Nuclear grooving, ovoid nucleus and clearing
when present diffusely showed almost 100% sensitivity and specificity. The importance
of nuclear features in the diagnosis FVPTC was demonstrated by Devi et al [18]
and Kunjumon et al [2], all of which were comparable to our study.
Conclusion
No
previous attempts has been made in the past to score benign and malignant
lesions of thyroid. The score proposed did help us to make a definite distinction
between benign and PTC cases in routine practice when diagnosis was made upon
integration. Such a scaled score may be a useful tool in this field of thyroid
pathology.
The
limitation of the study is that this score could be further tested by different
teams of pathologists on different variants of PTC. This study shows that no
single morphological feature is diagnostic of PTC and that a diagnosis is made
upon the integration of various morphological features.
Author contribution
Concept and design:
Dr. Swathi C Prabhu, Manuscript preparation:
Dr. Swathi C. Prabhu, Dr. Umashankar T, Manuscript
editing and manuscript review: Dr. Umashankar T.
Conflict of Interest:
None initiated
References